Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$1.06 - $1.97 $1,590 - $2,955
1,500 Added 5.64%
28,111 $31,000
Q4 2022

Feb 14, 2023

SELL
$1.4 - $25.4 $1,945 - $35,306
-1,390 Reduced 4.96%
26,611 $38,000
Q2 2022

Aug 09, 2022

BUY
$12.3 - $27.3 $5,535 - $12,285
450 Added 1.63%
28,001 $43,000
Q1 2022

Aug 09, 2022

BUY
$16.6 - $32.3 $457,346 - $889,897
27,551 New
27,551 $43,000

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $133M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track This Portfolio

Track Verus Capital Partners, LLC Portfolio

Follow Verus Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verus Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verus Capital Partners, LLC with notifications on news.